HOWE & RUSLING INC - SYROS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
HOWE & RUSLING INC ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$1,000
-50.0%
50
-66.7%
0.00%
Q2 2018$2,0000.0%1500.0%0.00%
Q1 2018$2,000
+100.0%
150
+50.0%
0.00%
Q4 2017$1,0001000.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 3,439,895$18,747,0004.66%
Bain Capital Life Sciences Investors, LLC 5,785,036$31,528,0002.07%
Omega Fund Management, LLC 2,274,831$12,398,0001.40%
Altium Capital Management LP 1,076,942$5,869,0001.36%
Samsara BioCapital, LLC 2,189,199$10,599,0001.31%
Sio Capital Management, LLC 800,000$4,360,0001.08%
Flagship Pioneering Inc. 2,938,494$16,015,0000.20%
EcoR1 Capital, LLC 1,000,000$5,450,0000.20%
Artal Group S.A. 1,700,000$9,265,0000.19%
ACT CAPITAL MANAGEMENT, LLC 52,500$287,0000.15%
View complete list of SYROS PHARMACEUTICALS INC shareholders